Evrofarma SA Cash Flow Reinvestment Rate

Latest as of December 2022: 0.41x

Evrofarma SA cash flow reinvestment rate. Evrofarma SA (EVROF) has a Cash Flow Reinvestment Rate of 0.41x as of December 2022, reinvesting €615.00K (capex €615.00K ) from operating cash flow of €1.52 Million. Explore Evrofarma SA (EVROF) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.41x
(Capex + Investments) / Operating CF

Total Reinvested

€615.00K
Capex + Investments

Operating Cash Flow

€1.52 Million
EUR

Capital Expenditures

€615.00K
EUR

Cash Flow Reinvestment Rate of Evrofarma SA (2014–2022)

Cash flow reinvestment rate of Evrofarma SA from 2014 to 2022. Historical reinvestment intensity for Evrofarma SA across 8 annual periods. Explore capital reinvestment ratio of Evrofarma SA to see what proportion of operating cash flow is directed to capital expenditures.

Evrofarma SA Cash Flow Reinvestment Rate by Year (2014–2022)

Evrofarma SA cash flow reinvestment rate by year from 2014 to 2022. Year-by-year capital reinvestment analysis for Evrofarma SA. For the full cash flow conversion analysis, see EVROF cash flow conversion.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2022 0.84x €2.05 Million €2.44 Million €2.05 Million ▲ +35.8%
2020 0.62x €904.00K €1.46 Million €904.00K ▲ +26.0%
2019 0.49x €875.00K €1.78 Million €875.00K ▲ +37.2%
2018 0.36x €822.00K €2.29 Million €822.00K ▲ +37.5%
2017 0.26x €810.00K €3.11 Million €810.00K ▲ +9.3%
2016 0.24x €258.00K €1.08 Million €258.00K ▼ -47.5%
2015 0.45x €632.00K €1.39 Million €512.00K ▼ -45.8%
2014 0.84x €727.00K €866.00K €607.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow